Earnings
Home›Earnings›Previews›Oura Health targets about $16 billion valuation in US…
Oura Health targets about $16 billion valuation in US IPO
Oura is reportedly seeking up to $3 billion in proceeds, at a valuation near $16 billion, with 2026 sales projected around $2 billion.
Oura Health is reportedly preparing for a U.S. IPO that could test investor demand for pure-play wearable health platforms, with the company targeting a valuation closing in on $16 billion, according to MarketBeat Ratings.
The report says Oura could raise up to $3 billion in the offering. It also points to an expected path for revenue, projecting about $2 billion in sales in 2026 and implying roughly an 8.0x forward revenue multiple at the $16 billion valuation.
MarketBeat Ratings frames the potential pricing as a form of price discovery for wearable businesses that pair devices with recurring software subscriptions, rather than relying on one-time hardware sales.
If institutional investors validate the premium, the IPO could also influence how Wall Street values wearable divisions at larger tech ecosystems by highlighting the value of ongoing health data processing and subscription economics, the outlet added.